Evaluating clinician led and patient empowered CGM SOLUTIONS : customizing based on patient needs

Speciality: All Speciality


Speaker:

Dr. Jothydev Kesavadev | Chairman and Managing Director Jothydevs Diabetes Research Center, Trivandrum

Description:

A warm welcome to all the medical professionals in this interesting session on Assessing CGM solutions: blend clinician guidance with patient autonomy for tailored diabetes care.

Evaluating CGM solutions involves balancing clinician-led oversight with patient empowerment, ensuring customization based on individual needs. Clinician-led approaches provide expert guidance, structured care, and standardized protocols, offering a foundation of support and expertise. Conversely, patient empowerment emphasizes autonomy and self-management, enabling individuals to make real-time decisions and adapt their treatment according to lifestyle and preferences.

Customization involves tailoring education, alert settings, and treatment plans to meet diverse patient needs. By integrating both approaches, healthcare providers can offer personalized care that combines clinical expertise with patient preferences and lifestyle factors. This collaborative approach fosters a sense of ownership and responsibility for managing diabetes while benefiting from professional guidance and support.

Ultimately, evaluating CGM solutions should consider how well they balance clinician-led guidance with patient empowerment, ensuring that each individual receives personalized care that optimizes their diabetes management journey.

Therefore, get an overall knowledge on Assessing CGM solutions: blend clinician guidance with patient autonomy for tailored diabetes care. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessi

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study opens up possibility of bespoke prostate cancer treatment

2.

Why Encouragement May Not Improve Motivation in Depression

3.

Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients

4.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

5.

Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot